Zydus Cadila gets USFDA nod for diabetes medication
Business | September 06, 2021 13:24 ISTThe NDA received tentative approval upon completion of the first review cycle on September 2, 2021, Zydus Cadila stated.
The NDA received tentative approval upon completion of the first review cycle on September 2, 2021, Zydus Cadila stated.
Diabetes patients on glucose-lowering drugs are at risk of rare Covid-19 complications, especially those who use a popular class of diabetes drugs called sodium-glucose cotransporter 2 inhibitors (SGLT2i), which function by releasing excess glucose in the urine.
The Competition Commission of India has initiated probe against four drugmakers for alleged price fixing of a popular anti-diabetic drug.
The findings published in the New England Journal of Medicine, revealed that the drug called canagliflozin, reduce the risk of cardiovascular disorders by up to 14% and heart failure hospitalization by 33%.
There are certain kind of bacteria that penetrate the mucous lining of the colon which may promote metabolic disease, especially type-2 diabetes.
Older women, over 75, taking statins -- cholesterol-lowering drugs -- may be at 33 per cent increased risk of developing diabetes, according to study. The risk increased to over 50 per cent for women taking
A latest research on diabetes reveals that injecting a particular weight loss drug along with a combination of specific diet and exercise regime may help in reducing risk of diabetes by 80 per cent in
London: A common diabetes drug Metformin can also help lower “bad” cholesterol that is known for promoting cardiovascular diseases by hardening the arteries, significant research has found."The findings suggest that Metformin might indeed have an
Washington, Jul 25: In a major crackdown on illegal sale of India-originating drugs labelled as ‘natural' cure for diabetes, the US health regulator FDA has initiated action against 15 companies, including a Gujarat-based drugmaker, for
Top News
Latest News
